Biontech Stock – BioNTech SE ADR outperforms competitors on strong trading day
The BioNTech SE ADR
rose 1.54% to $117.15 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index
falling 0.10% to 4,073.94 and Dow Jones Industrial Average
falling 0.29% to 33,430.24. This was the ADR’s eighth consecutive day of gains. BioNTech SE ADR closed $13.85 below its 52-week high ($131.00), which the company achieved on December 11th.
The ADR outperformed some of its competitors Tuesday, as AbbVie Inc.
fell 0.72% to $105.38 and Amgen Inc.
fell 1.16% to $249.10. Trading volume (1.5 M) remained 145,123 below its 50-day average volume of 1.7 M.